CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joffe, D.
Right arrow Articles by Benjamin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joffe, D.
Right arrow Articles by Benjamin, A.

Canadian Journal of Anesthesia, Vol 40, 870-874, Copyright © 1993 by Canadian Anesthesiologists' Society

ARTICLES

Caesarean section and phaeochromocytoma resection in a patient with Von Hippel Lindau disease

D Joffe, R Robbins and A Benjamin
Department of Anaesthesia and Obstetrics, McGill University, Montreal, Quebec.

This report describes the anaesthetic management of a women with a term gestation, Von Hippel Lindau disease (VHLD), and a phaeochromocytoma, scheduled for a combined phaeochromocytoma resection and Caesarean section. Von Hippel Lindau disease is characterized by diffuse haemangioblastomas of the central nervous system (CNS) and viscera. It is also associated with phaeochromocytomas and renal cell carcinomas. Patients frequently have asymptomatic spinal cord and intracranial pathology. The patient and her fetus presented a challenge because of the anaesthetic restrictions imposed by VHLD, and her pregnancy. She was also at risk of developing malignant hypertension from the phaeochromocytoma. The patient was not a candidate for regional anaesthesia because of the possibility of spinal cord haemangioblastomas. She had received adrenergic blockade with phentolamine (total 30 mg a day) and propranolol (total 40 mg a day) since the 27th wk of gestation in order to control hypertension secondary to the phaeochromocytoma. General anaesthesia was administered with aggressive management of hypertension with adrenergic blockers (labetalol 1.0 mg.kg-1 and esmolol 0.75 mg.kg-1) and sodium nitroprusside 1.5 micrograms.kg-1 (total). Before delivery of the baby, opioids, which could have resulted in a fetus with CNS depression, were avoided. After delivery, opioids (sufentanil 0.4 microgram.kg-1 x hr-1) were used to limit the use of inhalational anaesthesia which may contribute to uterine atony. Postoperative pain was managed with an intravenous narcotic infusion. Both patients had uneventful postoperative courses.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
A. Boker and B. Y. Ong
Anesthesia for Cesarean section and posterior fossa craniotomy in a patient with von Hippel-Lindau disease
Can J Anesth, April 1, 2001; 48(4): 387 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
C. Prys-Roberts
Phaeochromocytoma--recent progress in its management
Br. J. Anaesth., July 1, 2000; 85(1): 44 - 57.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Wang and R. S. Sinatra
Epidural Anesthesia for Cesarean Section in a Patient with von Hippel-Lindau Disease and Multiple Sclerosis
Anesth. Analg., May 1, 1999; 88(5): 1083 - 1084.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Canadian Anesthesiologists' Society.